Additionally, the intravitreal route of dosing produces side effects such as eye-floaters, vision deficits, retinal detachment, blindness, and possibly death due to thromboembolic events caused by VEGF-induced increase in nitric oxide in the patient’s plasma [12,13,14]. Here, VEGFA is linked to retinal detachment.